Moreover, in IBC patients, overexpression of PD-L1 was associated with several clinical and molecular findings, including estrogen receptor-negative status, basal and ERBB2-enriched subtypes, and a gene signature suggestive of an apparent cytotoxic T-lymphocyte (CTL) response. Here, CD274 is linked to inflammatory breast carcinoma.